0078-0331 : Simulect 20 mg/5ml Intravenous Injection, Powder, for Solution


NDC: 0078-0331
Labeler: Novartis Pharmaceuticals Corporation
Product Type: Human Prescription Drug
Drug Name:  Simulect
Dosage Form: Intravenous Injection, Powder, for Solution
Application #: BLA103764
Rev. Date: 


NDC Package Codes:

  • 0078-0331-84: 1 VIAL, SINGLE‑USE IN 1 CARTON (0078‑0331‑84) > 5 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Basiliximab

Dosage Strength:

  • 20 mg/5mL

Pharmaceutical Classes:

  • Interleukin 2 Receptor Antagonists [MoA]
  • Interleukin 2 Receptor-directed Antibody Interactions [MoA]
  • Interleukin-2 Receptor Blocking Antibody [EPC]

Related Products:

Based on records with the same trade name.
  • 0078-0393 Simulect 10 mg/2.5ml Intravenous Injection, Powder, for Solution by Novartis Pharmaceuticals Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0078-0331 QR Code

< Prev: 0078-0327Next: 0078-0337 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.